Gilead March volatility low as shares pullback from record high

Gilead gets positive CHMP opinion on extended indication for Viread The EMA's Committee for Medicinal Products for Human Use adopted a positive opinion recommending a variation to the terms of the marketing authorization for the medicinal product Viread.

http://www.theflyonthewall.com/permalinks/entry.php/GILDid1809218/GILD-Gilead-March-volatility-low-as-shares-pullback-from-record-high--